Insulet Corporation Common Stock
(NASDAQ:PODD)
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.
PODD Overview
None
Sector |
Health Care |
Industry |
Medical/Dental Instruments |
Previous Close |
$285.2700 |
Previous Close Volume |
389340 |